№ lp_2_3_30350
File format: docx
Character count: 2421
File size: 434 KB
Year:
2017
Region / city:
Victoria, ACT
Topic:
Drug safety, harm reduction
Document type:
Advisory notice
Organization:
Harm Reduction Victoria
Author:
Not specified
Target audience:
Public, drug users, healthcare professionals
Effective date:
Not specified
Date of approval:
Not specified
Date of amendments:
Not specified
Context:
Warning about the presence of dangerous synthetic drugs 25C-NBOMe and 4-FA sold as ‘2C-B’, with information on their adverse effects and harm reduction.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
Maryland
Topic:
Pre-eclampsia, Magnesium toxicity
Document Type:
Case Study
Institution:
Carroll Community College
Author:
Christine Schlaerth, PhD, RN, CNM, WHNP-BC
Target Audience:
Nursing students, healthcare professionals
Period of validity:
N/A
Approval Date:
N/A
Date of modification:
N/A
Year:
2023
Region / City:
Minnesota
Topic:
Effluent Toxicity Testing
Document Type:
Report
Organization / Institution:
Minnesota Pollution Control Agency (MPCA)
Author:
Minnesota Pollution Control Agency (MPCA)
Target Audience:
Environmental regulators, facility operators, testing laboratories
Period of Effectiveness:
Ongoing (based on NPDES permit)
Approval Date:
Not specified
Modification Date:
Not specified
Year:
Not specified
Region / City:
Not specified
Theme:
Bacterial Protein Synthesis Inhibitors, Antibiotics
Document Type:
Research Article / Scientific Paper
Organ / Institution:
Not specified
Author:
Adimula Sharon Ebere
Target Audience:
Medical professionals, researchers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Malaysia
Topic:
Life cycle toxicity assessment of wastewater treatment
Document Type:
Research article
Institution:
University of Southampton
Author:
Siti Safirah Rashid, Yong-Qiang Liu
Target Audience:
Researchers, environmental engineers, policy makers
Period of validity:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Ohio, USA
Topic:
Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type:
Research Article
Organization / Institution:
The Ohio State University, Wexner Medical Center
Author:
Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience:
Researchers, Scientists, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Context
Year:
2018
Region / city:
Alfred, NY
Subject:
Biology, Biochemistry
Document type:
Research article
Organization / institution:
Alfred University, Department of Biology
Author:
Geoffrey Lippa
Target audience:
Students in biological sciences
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Year:
2002
Product name:
Abine (Abamectina 1.8% p/v)
Active substance:
Abamectin
Study type:
Acute oral toxicity study; Acute dermal toxicity study
Test guidelines:
OECD No. 423; OECD No. 402
GLP compliance:
Yes
Laboratory:
Jai Research Foundation
Location:
Valvada 396 108; Gujarat; India
Author:
Aldrin Joseph, S.
Document numbers:
JRF 3719; JFR 3720
Test species:
Rat (Wistar)
Sex:
Male and female
Route of administration:
Oral (gavage); Dermal (semi-occlusive, 24 h)
Dose levels:
200, 500, 2000 mg/kg bw (oral); 2000 mg/kg bw (dermal)
Oral LD50:
500–2000 mg/kg bw
Dermal LD50:
> 2000 mg/kg bw
Observation period:
14 days
Regulatory references:
Directive 2001/59/EC; Regulation (EC) 1272/2008; Council Directive 67/548/EC
Hazard classification:
R22 (Harmful if swallowed); H302 (Harmful if swallowed); H318 (Causes serious eye damage)
Year:
2021
Region / City:
Makassar
Subject:
Environmental Science, Marine Biology
Document Type:
Research Article
Organization:
University of Fajar, Faculty of Engineering
Author:
Ismail Marzuki, Iksan Ashari, Andi Asdar Marzuki, Anggi Angela
Target Audience:
Academics, Researchers, Environmental Scientists
Period of Validity:
Not applicable
Approval Date:
Not specified
Date of Revision:
Not specified
Year:
2023
Region / City:
Not specified
Topic:
Antioxidants, Toxicity, Biochemistry
Document Type:
Research Study
Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, Pharmacologists, Biochemists
Period of Action:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2026
Region / City:
Not specified
Subject:
Toxicology
Document Type:
Medical summary
Institution / Organization:
Medical or educational source
Author:
Not specified
Target Audience:
Healthcare professionals and medical students
Period Covered:
Acute and chronic exposure scenarios
Date of Compilation:
2026
Symptoms Covered:
Gastrointestinal, hematologic, neurologic, reproductive, hepatic, cardiovascular, respiratory
Investigations Included:
Blood tests, X-rays, COHb measurement
Treatment Approaches:
Chelation therapy, supportive care, emergency measures
Chemical Agents Discussed:
Lead, Iron, Carbon Monoxide
Year:
2022
Region / city:
Netherlands
Topic:
Cancer treatment, Abiraterone, Prostate cancer
Document type:
Research study
Institution:
Ziekenhuis Gelderse Vallei, Radboudumc
Author:
Indy Murdoch, Emmy Boerrigter, Arnold Baars, Floor Lubberman
Target audience:
Healthcare professionals, Researchers
Period of validity:
N/A
Date of approval:
February 4, 2022
Date of changes:
N/A
Year:
2022
Region / City:
Saudi Arabia
Topic:
Autoimmune Diseases, Hydroxychloroquine Toxicity, Physician-Patient Communication
Document Type:
Scientific Article
Organization / Institution:
Not specified
Author:
Aldarwesh A, Almustanyir A, Alharthi M, Alhayan D
Target Audience:
Medical professionals, Researchers
Period of Action:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Keywords:
Hydroxychloroquine, Autoimmune Diseases, Physician-Patient Communication, Toxicity
Note:
Contextual Description
Year:
2026
Region / City:
Multicenter, international
Topic:
Pharmacogenetics, oncology, hepatotoxicity
Document type:
Supplementary data tables
Institution:
Pharmaceutical research consortium
Author:
Multiple clinical investigators
Target population:
Patients with various cancers receiving pazopanib
Study phases:
I–III clinical trials
Total participants:
3,190
Genetic focus:
HLA-B*57:01, rs1800625, UGT1A1 variants
Primary tumors:
Renal cell carcinoma, ovarian cancer, soft tissue sarcoma, and others
Endpoints:
ALT elevation, DILI, Hy’s Law assessment
Data collection period:
Various, corresponding to each trial
Statistical measures:
Odds ratio, hazard ratio, confidence interval, P values
Analytical methods:
Pharmacogenetic association, sensitivity analyses, GWAS
Year:
2023
Region / City:
Québec, Canada; Pessac, France
Subject:
Ecotoxicology, Aquatic Toxicology
Document Type:
Research Article
Institution:
Institut National de la Recherche Scientifique – Centre Eau Terre Environnement; Univ. Bordeaux, CNRS, EPOC, EPHE
Authors:
Charlotte Bourdon, Jérôme Cachot, Patrice Gonzalez, Patrice Couture
Target Audience:
Researchers in ecotoxicology and environmental sciences
Study Species:
Oncorhynchus mykiss juveniles
Exposure Type:
Acute and chronic copper pyrithione exposure
Measured Parameters:
Mortality rates, growth, antioxidant enzyme activity, gene expression
Keywords:
Copper pyrithione, antifouling, copper sulphate, rainbow trout juveniles, lethal toxicity, sub-lethal toxicity, oxidative stress, gene expression
Abstract Focus:
Comparative toxicity of CuPT and CuSO4 on rainbow trout
Field:
Ecotoxicology
Document type:
Supporting information file
Content type:
Methodological appendix with model formulations and simulation data
Subject:
Estimation of no-effect toxicity concentrations (NEC) and ECx metrics
Models described:
NEC3param, NEC4param, ECxLinear, ECxExp, ECxSigmoidal, ECx4param, ECxWeibull1, ECxWeibull2
Software / framework:
jagsNEC (Bayesian modelling approach)
Key parameters:
τ (upper plateau / intercept), η (NEC), β (decay rate), δ (lower plateau), ω (EC50)
Methods included:
Threshold models, sigmoidal decay models, Weibull models
Data type:
Simulated toxicity and concentration–response data
Simulation design:
Multiple sampling schemes with varying treatment levels, replicates, and binomial trials
Measured variable:
Concentration–response relationships for toxicity effects
Chemical context:
Weathered Ichthys condensate WAF expressed as Total Aromatic Hydrocarbons (µg/L TAH)
Biological context:
Tropical marine species responses including A. millepora, S. variolaris, N. dorsatus, and A. amphitrite
Statistical approach:
Bayesian model fitting with MCMC and DIC-based model weighting
Included materials:
R functions for simulation data generation, model equations, simulation study tables, and figure of fitted concentration–response curves
Tables:
Model weight comparison (Table S1); toxicity estimates and effects across simulation designs (Table S2)
Figure:
Concentration–response relationships with Bayesian NEC-sigmoidal model fits (Figure S1)
Year:
2021
Region / City:
-
Subject:
Automotive Fluid
Document Type:
Product Data Sheet
Organization / Institution:
Chemlube International
Author:
-
Target Audience:
-
Period of Validity:
-
Approval Date:
-
Date of Changes:
02-09-21
Context:
This product data sheet provides detailed information about the specifications, features, and typical applications of Chemlube Synthetic MVATF, a synthetic automatic transmission fluid for modern and older fuel-efficient transmissions.
Year:
2021
Region / City:
Rwanda
Subject:
Quality information for product dossiers containing APIs
Document Type:
Template
Organization / Institution:
Rwanda FDA
Author:
Not specified
Target Audience:
Manufacturers and regulatory bodies
Validity Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2022
Region / City:
Saipan, Commonwealth of the Northern Mariana Islands
Topic:
Environmental Quality, Air Emissions
Document Type:
Technical Support Document
Agency / Institution:
Bureau of Environmental and Coastal Quality, Commonwealth of the Northern Mariana Islands
Author:
Eli D. Cabrera, Zabrina S. Cruz
Target Audience:
Environmental regulators, stakeholders in environmental compliance
Period of Effect:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Subject:
Biosafety, Recombinant Nucleic Acids, Synthetic Nucleic Acids, Biohazardous Materials
Document Type:
Registration Form
Institution:
Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s Hospital of Chicago
Target Audience:
Researchers conducting experiments involving recombinant or synthetic nucleic acids or biohazardous materials
Programme:
CSIRO Future Science Fellowships in Synthetic Biology
Document Type:
Full Proposal CV Template
Organisation:
CSIRO
Field:
Synthetic Biology
Content Sections:
Academic Qualifications; Employment History; Honours and Awards; Career Overview; Research End User and Societal Impacts; Major Funding Support; Publications and Metrics; Five Key Publications; Conference Presentations; Service and Discipline Involvement; Mentoring and Research Training; Teaching Contributions; Output Relative to Opportunity; Career Interruptions
Funding Currency:
AUD
Purpose:
Submission of applicant curriculum vitae for fellowship assessment